On Jan 11, 2022 Transcarent closed a Series C round and raised $200,000,000 from 7wire Ventures, Ally Bridge Group, Alta Partners, General Catalyst, GreatPoint Ventures, Human Capital, Intermountain Healthcare, Jove Equity Partners, Kinnevik AB, Merck Global Health Innovation Fund, Northwell Health, Rush Presbyterian St. Lukes Hospital, Threshold, featuring lead investors Human Capital, Kinnevik AB.
About the company: Transcarent is located at United States, North America.
“”
Company website: http://www.transcarent.ai